Harris Taylor C. 4

What Happened

• Harris Taylor C., a Director of PROCEPT BioRobotics (PRCT), received equity awards on June 9, 2026. The filing shows a grant of 3,315 restricted stock units (RSUs) and a 5,853-share derivative award (reported as an acquisition) — 9,168 total units — each at $0.00 per share (no immediate cash proceeds). These are compensation awards, not open-market purchases or sales.

Key Details

• Transaction date: 2026-06-09; Form filed: 2026-06-10 (appears timely).
• Grant amounts and price: 3,315 RSUs @ $0.00; 5,853 derivative award units @ $0.00; total units = 9,168; immediate cash value = $0.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes: F1 — the 3,315 are RSUs, each convertible to one share; F2 — the derivative award is a stock option granted 6/9/2026. Both awards vest in full on the earlier of (i) the one‑year anniversary of the grant or (ii) the next annual meeting, subject to continued service.
• Transaction code: A = Award/Grant. No sale or purchase code reported.

Context

• These awards are compensation-related grants (RSUs/options) and carry no immediate cash value until vesting and any subsequent conversion/exercise. They do not indicate an immediate buy or sell in the market. Vesting is time- and service-based, so any future shares or proceeds depend on vesting and whether the director later exercises or sells shares.